Food safety legislation would require warning labels for some dyes and chemicals
HARRISBURG, Pa. (WHTM) – New bipartisan legislation would increase awareness about what's in food. Products that contain certain dyes and chemicals would be required to have warning labels.
Currently, companies can add new 'Generally Recognized as Safe' chemicals to food without any type of FDA approval or independent review through an FDA loophole. If this legislation passes, companies that manufacture, distribute, or sell food products in the Commonwealth will have to disclose the use of those substances and document that they're safe.
'People need to understand what's in their food,' says Rep. Justin Fleming. 'They need to understand what they're eating.'
Rep. Fleming says there are students who get most of their meals at school, so those meals need to be safer.
'There are all these dyes in food and it's no secret, we as Americans are getting sicker, unfortunately, and it's it's due in large part to what we're eating. Levels of diabetes have gone up with more high fructose corn syrup,' Fleming says.
Under the legislation, products with Red 40, Yellow 5, Yellow 6, Blue 1, Blue 2 and Green 3 could no longer be served in any Pennsylvania public school and those items would need labels warning consumers that the product may affect children's behavior and health.
'If this is something we can really look at and see if it's going to correct those behavior issues, it's going to be great in the long run for educators also,' says Dennis Michaels with Metz Culinary Management.
Michaels oversees schools in the central Pennsylvania region, including Carlisle, Fulton and Mifflin school districts.
'We have a captured audience for those two meals a day, so it's something that we can really influence at any age, but especially at a young age, introducing very healthy, fresh food to them, chemical free dye free, that could really help guide their eating habits in the future,' Michaels says.
Both Fleming and Michaels say manufacturers are already making improvements and this legislation would offer more guidance for food production.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
an hour ago
- Newsweek
Dr Pepper Recall Issued After Sugar Mix Up in Thousands of Cans
A recall has been issued for thousands of cases of Dr Pepper Zero Sugar that were mislabeled and contained the full-sugar product, according to the U.S. Food and Drug Administration (FDA). The products were distributed to retailers in Florida, Georgia, and South Carolina. Newsweek contacted Keurig Dr Pepper, which owns the product in the United States, and PepsiCo, which bottled the beverages, for comment via email outside of regular working hours. Why It Matters This mislabeling poses potential health risks to consumers, particularly for individuals managing conditions like diabetes or those monitoring their sugar intake The FDA has issued a Class II risk classification for the recall, indicating that the consumption of the mislabeled products may cause temporary or medically reversible adverse health consequences. What To Know The FDA said the company-initiated recall affects 19,203 cases of Dr Pepper Zero Sugar 12-fluid ounce cans, sold in 12-pack and 24-pack cartons. The affected cans were produced at a Pepsi bottling facility in Jacksonville, Florida, which is licensed to manufacture Keurig Dr Pepper products, according to the FDA. The affected products have the product code XXXXRS05165, and a best-by date of February 16, 2026. The recall was initiated on May 23, 2025, and the FDA classified it as a Class II recall on June 5, 2025. A can of regular Dr Pepper contains 39 grams of sugar, while the Zero Sugar version has zero grams, but contains the artificial sweeteners aspartame and acesulfame potassium. There were 241 FDA food and beverage recalls in 2024, which was an increase of eight percent from the previous year, according to a report published by the nonprofit Public Interest Research Group. Undeclared allergens or ingredients was the single biggest cause for recalls that year. Last year, Dr Pepper tied with Pepsi to become the second most popular soda in the U.S. after Coca Cola, according to data from Beverage Digest. What Happens Next The FDA and Dr Pepper are working to ensure that all affected products are removed from store shelves promptly. Consumers in the affected states should remain vigilant and check their purchases to ensure they have not bought the mislabeled product.


Newsweek
an hour ago
- Newsweek
Can Tackling Addictions Reduce Medicaid Costs?
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Discussions around Medicaid costs have become more heated than ever in recent months as President Donald Trump's administration tries to push its budget bill through the legislative ranks. House Republicans have instructed the House Committee on Energy and Commerce to slash $880 billion in spending over the next decade, with Medicaid making up 93 percent of the committee's budget. As a result, the amount of money the federal Medicaid program needs to provide health care services for more than 70 million Americans has been under dispute, with some arguing there is significant waste and misuse of money in the system, while others have warned cuts would leave millions of vulnerable people without access to health care. While lawmakers continue debating the divisive legislation, experts have discussed with Newsweek whether there could be another way of reducing Medicaid costs—tackling substance use disorders. Medicaid enrollees with substance use disorders require significantly higher health costs than those without—around $1,200 per month on average compared to $550, according to KFF. Around 7.2 percent of Medicaid recipients age 12 to 64 have a diagnosed substance use disorder, and treatment is key to addressing overdoses, deaths and other health or social complications, KFF reported. So could tackling substance use disorders in turn reduce costs for the Medicaid program? Here's what experts told Newsweek. Photo-illustration by Newsweek/Getty/Canva Why Are Medicaid Costs Higher for Those With Substance Use Disorders? The reason Medicaid enrollees with substance use disorders have higher health costs is because they often also have additional health complications, Dr. Joshua Lynch, professor of emergency and addiction medicine at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, New York, told Newsweek. This could be physical health conditions, such as hypertension, high cholesterol and diabetes, or mental health disorders, "which can lead to more complex health care needs," he added. Those with substance use disorders also may "experience more fragmented care and more challenging access to high quality, lower cost care and preventative services," Lynch said. They may also struggle to work, or stay in work, and this may "contribute to increased reliance on higher-cost healthcare services," he added. Many Americans with substance use disorders also go undiagnosed, Brendan Saloner, professor of health policy and management at the John Hopkins Bloomberg School of Public Health, Maryland, told Newsweek. He added that those with substance addiction can have a lot of problems, such as the risk of overdose, or contracting blood-borne diseases like HIV or hepatitis C, as well as other issues, so "it's much better to get people into care proactively then to wait for their problems to become a crisis." The higher costs for those with substance use disorders, therefore, could "reflect the devastating physical consequences of substance use itself," Heidi Allen, professor of social work at the Columbia University School of Social Work, New York, told Newsweek, pointing to overdoses, increased vulnerability for chronic illness and exposure to infectious diseases. It's also not just about health complications, John Kelly, professor of psychiatry at Harvard Medical School and director of the Recovery Research Institute at Massachusetts General Hospital, told Newsweek. "The nature of these disorders means also that, on average, in the Medicaid population, individuals suffering from substance use disorder tend to have more social instability in terms of secure housing, employment, and criminal justice complications. These all contribute to increased costs," he said. Could Tackling Substance Use Disorders Reduce Medicaid Costs? While tackling substance use disorders may not slash Medicaid costs in the short term, as it would require investment in prevention and treatment, it could have positive economic impacts in the long run. "Prioritizing substance use treatment for enrollees might not reduce Medicaid costs in the short term, since we would expect more Medicaid enrollees to engage with treatment, which itself costs money," Allen said. However, she added that "it could certainly improve the health of enrollees, which might result in Medicaid savings down the road." If patients also have access to high-quality treatment and are able to manage their condition, "they have a lower reliance on high-cost health care such as emergency visits and inpatient hospitalizations," Lynch said. He added that other comorbidities also become more manageable, while housing stability and employment turn more achievable. "All of these will lead to a decrease in overall Medicaid spending," he said. Kelly also said he thought that tackling substance use disorders could reduce costs for Medicaid, adding that "focus on earlier intervention, and better implementation of care coordination will result in reduced use of more expensive acute medical care services, as well as prevention of the contraction of more chronic disease such as alcohol-associated liver diseases, HIV and hepatitis infections." "I am very confident that it would help to prevent some long-term costs to the program and would have a huge impact on other non-health needs like employment and reduced incarceration," Saloner said. But he added that whether it fully pays for itself, or saves money, is a more difficult question to answer. "We have some older studies showing that substance use care can offset lots of costs to society, but purely from the perspective of the Medicaid budget it's hard to say. The quality of life gains make it very cost-effective, whether or not it's cost saving," he said. Carrie Fry, professor in the department of health policy at Vanderbilt University School of Medicine, Tennessee, told Newsweek: "Research shows that addressing substance use disorder with effective, evidence-based treatments reduces Medicaid costs." In order to cut Medicaid costs, Fry said, making it easier for people with substance use disorders "to start and remain on effective treatment" would be an important step in the process. "For opioid use disorder, this means expanding availability of medications for opioid use disorder including methadone, buprenorphine, and naltrexone," she said. She added that only about half of Medicaid enrollees with an opioid use disorder receive evidence-based treatment in a given year. "So, treatment is an important first step to addressing the burden of substance use disorders in Medicaid and can reduce or prevent additional downstream costs," Fry said. She added that reducing the prevalence of substance use disorder via prevention will "require a more comprehensive approach to addressing broader social conditions that lead to increased risk of developing a substance use disorder."
Yahoo
9 hours ago
- Yahoo
FDA Reveals Which Kinds of Eggs May Be Contaminated with Salmonella
In a June news release, the U.S. Food and Drug Administration revealed that "brown cage-free and brown certified organic eggs" from the August Egg Company have "the potential" to be contaminated with salmonella. The outlet added that the eggs were "sold under multiple different brand names at restaurants and retailers" and should "no longer be available for sale." Those brands are Clover, First Street, Nuaid, O Organics, Marketside, Raleys, Simple Truth, Sun Harvest, and Sunnyside. According to People, over 1.7 million eggs have been recalled in nine states: California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois. On June 6, 2025, the Centers for Disease Control and Prevention revealed they were investigating the "multi-state outbreak of salmonella infections." Mayo Clinic states that while some people with salmonella may have no symptoms, most experience a range of symptoms, like abdominal cramps, within 8 to 72 hours. "In some cases, diarrhea can cause severe dehydration and requires prompt medical attention. Life-threatening complications also may develop if the infection spreads beyond the intestines. The risk of getting salmonella infection is higher with travel to countries without clean drinking water and proper sewage disposal." At this time, 21 people have been hospitalized due to infection, according to the FDA. In a statement, the August Egg Company shared, "We believe it is appropriate out of an abundance of caution to conduct this voluntary recall, as consumers may still have these eggs in their homes. It is important to know that when our processing plant identified this concern, we immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens." The company concluded, "We are committed to addressing this matter fully and to implementing all necessary corrective actions to ensure this does not happen again."FDA Reveals Which Kinds of Eggs May Be Contaminated with Salmonella first appeared on Men's Journal on Jun 7, 2025